- Home
- NBTX vs CTS Comparison
NBTX vs CTS Comparison
Compare NBTX & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- CTS
- Stock Information
- Founded
- NBTX 2003
- CTS 1896
- Country
- NBTX France
- CTS United States
- Employees
- NBTX N/A
- CTS N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- CTS Electrical Products
- Sector
- NBTX Health Care
- CTS Technology
- Exchange
- NBTX Nasdaq
- CTS Nasdaq
- Market Cap
- NBTX 1.3B
- CTS 1.2B
- IPO Year
- NBTX 2020
- CTS N/A
- Fundamental
- Price
- NBTX $21.69
- CTS $41.56
- Analyst Decision
- NBTX Strong Buy
- CTS
- Analyst Count
- NBTX 1
- CTS 0
- Target Price
- NBTX $8.00
- CTS N/A
- AVG Volume (30 Days)
- NBTX 99.0K
- CTS 235.8K
- Earning Date
- NBTX 09-30-2025
- CTS 10-28-2025
- Dividend Yield
- NBTX N/A
- CTS 0.39%
- EPS Growth
- NBTX N/A
- CTS 3.07
- EPS
- NBTX N/A
- CTS 1.98
- Revenue
- NBTX $11,930,711.00
- CTS $531,522,000.00
- Revenue This Year
- NBTX N/A
- CTS $5.73
- Revenue Next Year
- NBTX $122.94
- CTS $4.00
- P/E Ratio
- NBTX N/A
- CTS $20.89
- Revenue Growth
- NBTX N/A
- CTS 3.61
- 52 Week Low
- NBTX $2.76
- CTS $34.02
- 52 Week High
- NBTX $30.35
- CTS $57.49
- Technical
- Relative Strength Index (RSI)
- NBTX 53.91
- CTS 52.04
- Support Level
- NBTX $19.90
- CTS $40.16
- Resistance Level
- NBTX $23.56
- CTS $42.56
- Average True Range (ATR)
- NBTX 1.39
- CTS 1.41
- MACD
- NBTX 0.06
- CTS -0.03
- Stochastic Oscillator
- NBTX 69.36
- CTS 41.12
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.